Analysts' Top Healthcare Picks: Opthea Limited (CKDXF), Boston Scientific (BSX)
JonesTrading Maintains Opthea(OPT.US) With Buy Rating, Maintains Target Price $13
Opthea Analyst Ratings
H.C. Wainwright Maintains Opthea(OPT.US) With Buy Rating, Maintains Target Price $12
Analysts' Opinions Are Mixed on These Healthcare Stocks: GlaxoSmithKline (GB:GSK), CSL (OtherCMXHF) and Opthea Limited (OtherCKDXF)
Bell Potter Sticks to Its Buy Rating for Opthea Limited (CKDXF)
JonesTrading Maintains Opthea(OPT.US) With Buy Rating, Maintains Target Price $13
Optimistic Buy Rating for Opthea Limited: Sozinibercept's Promising Phase 3 Potential and Market Positioning
Canaccord Genuity Keeps Their Buy Rating on Opthea Limited (CKDXF)
JonesTrading Maintains Opthea(OPT.US) With Buy Rating, Maintains Target Price $13
Analysts Offer Insights on Healthcare Companies: Marinus (MRNS) and Opthea Limited (OtherCKDXF)
JonesTrading Maintains Opthea(OPT.US) With Buy Rating, Maintains Target Price $13
Opthea Limited: Strong Buy Rating on Manufacturing Milestones and Positive Financial Outlook
Citi Maintains Opthea(OPT.US) With Buy Rating, Cuts Target Price to $10
Analysts Are Bullish on These Healthcare Stocks: Eledon Pharmaceuticals (ELDN), Opthea Limited Sponsored ADR (OPT)
JonesTrading Initiates Opthea(OPT.US) With Buy Rating, Announces Target Price $13
H.C. Wainwright Maintains Opthea(OPT.US) With Buy Rating, Cuts Target Price to $12
Buy Rating Affirmed for Opthea Limited Amid Promising Wet AMD Combination Therapy Trials
Bell Potter Remains a Buy on Opthea Limited (CKDXF)
Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), Ultragenyx Pharmaceutical (RARE) and Opthea Limited Sponsored ADR (OPT)